Alterity Therapeutics Profit Margin

Alterity Therapeutics (ATHE) currently reports a profit margin of -396.9% as of December 2025. That compares with -1440.79% in the prior-year period — up 72.5% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Alterity Therapeutics's profit margin history and peer comparisons.

Alterity Therapeutics's profit margin increased from -1440.79% to -396.9% — a 72.5% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alterity Therapeutics's profit margin of -396.9% is lower than the Healthcare sector average of 14.34%. That is roughly 2866.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Alterity Therapeutics's current -396.9% should be judged against Healthcare norms (sector average: 14.34%) and against ATHE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -396.9%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Alterity Therapeutics, and consider following ATHE for alerts when major investors trade the stock.